Global Spinal Cord Stimulation Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.

Scope of the Report:
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2017 is about 66%, and the proportion is in increasing trend from 2013 to 2017. Spinal cord stimulation devices are widely used in failed back surgery syndrome, complex regional pain syndrome, chronic pain and other field. The most proportion of spinal cord stimulation devices is for failed back surgery syndrome, and the proportion in 2017 is 43.95%.
North America is the largest consumption place, with a consumption market share nearly 56% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro,
Nuvectra are the leaders of the industry. And top 3 account for around 79% of the total market share. These existing companies are making investments in several research activities to launch new devices.
The worldwide market for Spinal Cord Stimulation Devices is expected to grow at a CAGR of roughly 5.0% over the next five years, will reach 2890 million US$ in 2024, from 2160 million US$ in 2019, according to a new study.
This report focuses on the Spinal Cord Stimulation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Rechargeable
Non-Rechargeable

Market Segment by Applications, can be divided into
Failed Back Surgery Syndrome
Complex Regional Pain Syndrome
Chronic Pain
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spinal Cord Stimulation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Spinal Cord Stimulation Devices, with price, sales, revenue and global market share of Spinal Cord Stimulation Devices in 2017 and 2018.
Chapter 3, the Spinal Cord Stimulation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Cord Stimulation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Spinal Cord Stimulation Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Spinal Cord Stimulation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions